Migraine may be a risk factor for the development of complex regional pain syndrome

Cephalalgia

Volumn 30, Issue 2, 2010, Pages 214-223

  Peterlin, B L ^a   Rosso, A L ^a   Nair, S ^a   Young, W B ^b   Schwartzman, R J ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Allodynia; Aura; Chronic daily headache; Complex regional pain syndrome; Migraine

Indexed keywords

ADULT; ALLODYNIA; ANALYSIS OF VARIANCE; ARTICLE; CHRONIC DAILY HEADACHE; COMPLEX REGIONAL PAIN SYNDROME; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FISHER EXACT TEST; HEADACHE; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIGRAINE; MIGRAINE WITH AURA; MORBIDITY; ONSET AGE; PAIN CLINIC; POPULATION; POST HOC ANALYSIS; PREVALENCE; RISK FACTOR; STANDARDIZED MORTALITY RATIO; TENSION HEADACHE;

ADULT; AGE OF ONSET; COMPLEX REGIONAL PAIN SYNDROMES; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; QUESTIONNAIRES; RISK FACTORS;

EID: 77956253178     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2009.01916.x     Document Type: Article

References (40)

1. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007;68:343-9.
2. Bensen V, Marano M. Current estimates from the National Health Interview Survey, 1995. Vital Heath Stat 10 1998;199:1-428.
3. Schwartzman RJ, Erwin Kl, Alexander GM. The natural history of complex regional pain syndrome. Clin J Pain 2008; in press).
4. de Mos M, de Bruijn A G J, Huygen FJ, Dieleman JP, Stricker BH, Sturkenboom MC. The incidence of complex regional pain syndrome: a population-based study. Pain 2007;129:12-20.
5. Sandorni P, Benrud-Larson LM, McClelland RL, Low PA. Complex regional pain syndrome type I: incidence and prevalence in Olmsted county, a population-based study. Pain 2003;103:199-207.
6. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2nd edn. Cephalalgia 2004;24: S24-101.
7. Bruehl S, Harden RN, Galer BS, Saltz S, Bertram M, Backonja M, et al. External validation of IASP diagnostic criteria for complex regional pain syndrome and proposed research diagnostic criteria. Pain 1999;81:147-54.
8. Birklein F, Schmelz M, Schifter S, Weber M. The important role of neuropeptides in complex regional pain syndrome. Neurology 2001;26:2179-84.
9. Ashina M, Bendtsen L, Jensen R, Schifter S, Olesen J. Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks. Pain 2000;86:133-8.
10. Merritt WH. The challenge to manage reflex sympathetic dystrophy/complex regional pain syndrome. Clin Plast Surg 2005;32:575-604.
11. Toda K, Muneshige H, Maruishi M, Kimura H, Asou T. Headache may be a risk factor for complex regional pain synrome. Clin Rheumatol 2006;25:728-30.
12. de Mos M, Huygen F J P M, Dieleman JP, Koopman JS, Stricker BH, Sturkenboom MC. Medical history and the onset of complex regional pain syndrome. Pain 2008;139:568-66.
13. Bruehl S, Harden RN, Galer BS, Saltz S, Bertram M, Backonja M, et al. External validation of IASP diagnostic criteria for complex regional pain syndrome and proposed research criteria for the study of pain. Pain 1999;81:147-54.
14. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606-13.
15. Ware JE, Kosinski M, Keller SD. A 12-item short-form health survey. Med Care 1996;34:220-33.
16. Janke EA, Collins A, Kozalk AT. Overview of the relationship between pain and obesity: what do we know? Where do we go next? Rehabil Res Dev 2007;44:245-62.
17. Scher AI, Stewart WF, Ricci JA, Lipton RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 2003;106:81-9.
18. Peres MF, Lerário DD, Garrido AB, Zukerman E. Primary headaches in obese patients. Arq Neuropsiquiatr 2005;63:931-3.
19. World Health Organization. Physical status: the use and interpretation of anthropometry-report of a WHO expert committee. World Health Organ Tech Rep Ser 1995. 854.
20. Stewart WF, Lipton RB, Liberman J. Variation in migraine prevalence by race. Neurology 1996;47:52-9.
21. Kawata AK, Coeytaux RR, Devellis RF, Finkel AG, Mann JD, Kahn K. Psychometric properties of the HIT-6 among patients in a headache-specialty practice. Headache 2005;6:638-43.
22. ™. Qual Life Res 2003;12:963-74.
23. Jakubowski M, Silberstein S, Ashkenazi A, Burstein R. Can allodynic migraine patients be identified interictally using a questionnaire? Neurology 2005;65:1419-22.
24. Lipton RB, Bigal M, Ashina S, Burstein R, Silberstein S, Reed ML, et al. Cutaneous allodynia in the migraine population. Ann Neurol 2008;63:148-58.
25. Bigal ME, Liberman JN, Lipton RB. Age-dependent prevalence and clinical features of migraine. Neurology 2006;67:246-51.
26. Castillo J, Munoz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in the general population. Headache 1999;39:190-6.
27. Rasmussen BK. Epidemiology of migraine. In: Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA (eds) The headaches, 3rd edn. Philadelphia, PA: Lippincott Williams & Wilkins, 2006, p. 239-40.
28. Lyngberg AC, Rasmussen BK, Jorgensen T, Jensen R. Incidence of primary headache: a Danish epidemiologic follow-up study. Am J Epidemiol 2006;161:1066-73.
29. Cuadrado ML, Young WB, Fernandez-de-las-Penas C, Arias JA, Pareja JA. Migrainous corpalgia: body pain and allodynia associated with migraine attacks. Cephalalgia 2007;28:87-91.
30. Lauritzen M, Skyhoj Olson T, Lassen NA, Paulson OB. The regulation of regional cerebral blood flow during and between migraine attacks. Ann Neurol 1983;13:633-41.
31. Olesen J, Larsen B, Laurizen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol 1981;9:344-52.
32. Sakai F, Meyer JS. Regional cerebral hemodynamics during migraine and cluster headaches measured by the 133Xe inhalation method. Headache 1978;18:122-32.
33. Wu CT, Fan YM, Sun CM, Borel CO, Yeh CC, Yang CP, Wong CS. Correlation between changes in regional cerebral blood flow and pain relief in complex regional pain syndrome type 1. Clin Nucl Med 2006;31:317-20.
34. Fukui S, Shigemori S, Nosaka S. Changes in regional cerebral blood flow in the thalamus after electroconvulsive therapy for patients with complex regional pain syndrome type 1 (preliminary case seriers). Reg Anesth Pain Med 2002;27:529-32.
35. Becerra L, Schwartzman RJ, Kiefer RT, Rohr P, Moulton EA, Wallin D, et al. CNS measures of pain responses pre-and post-anesthetic ketamine in a patient with complex regional pain syndrome. Pain Med 2009; EPub doi:10.1111/j.1526- 4637.2009.00559.x.
36. Scher AI, Terwindt GM, Picavet HS, Verschuren WM, Ferrari MD, Launer MJ. Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 2005;22:614-20.
37. Ashkenazi A, Silberstein S, Jakubowski M, Burstein R. Improved identification of allodynic migraine patients using a questionnaire. Cephalalgia 2007;27:325-9.
38. Burstein R, Cutrer MF, Yarnitsky D. The development of cutaneous allodynia during a migraine attack. Brain 2000;123:1703-9.
39. Sarchielli P, Alberti A, Baldi A, Coppola F, Rossi C, Pierquidi L, et al. Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache 2006;46:200-7.
40. Alexander GM, Perreault MJ, Reichenberger ER, Schwartzman RJ. Changes in immune and glial markers in the CSF of patients with complex regional pain syndrom. Brain Behav Immun 2007;21:668-76.